186 related articles for article (PubMed ID: 26583911)
41. The Role of MicroRNA-21 in Venous Neointimal Hyperplasia: Implications for Targeting miR-21 for VNH Treatment.
Kilari S; Cai C; Zhao C; Sharma A; Chernogubova E; Simeon M; Wu CC; Song HL; Maegdefessel L; Misra S
Mol Ther; 2019 Sep; 27(9):1681-1693. PubMed ID: 31326400
[TBL] [Abstract][Full Text] [Related]
42. Impact of ex vivo administration of mesenchymal stem cells on the function of kidney grafts from cardiac death donors in rat.
Iwai S; Sakonju I; Okano S; Teratani T; Kasahara N; Yokote S; Yokoo T; Kobayash E
Transplant Proc; 2014 Jun; 46(5):1578-84. PubMed ID: 24935331
[TBL] [Abstract][Full Text] [Related]
43. Effect of umbilical cord mesenchymal stem cells on hypoxia-inducible factor-1 alpha (HIF-1α) production in arteriovenous fistula (AVF) animal model: A preliminary study.
Habibie YA; Emril DR; Azharuddin A; Syahrizal D
Narra J; 2023 Dec; 3(3):e225. PubMed ID: 38455624
[TBL] [Abstract][Full Text] [Related]
44. In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula.
Cui J; Kessinger CW; McCarthy JR; Sosnovik DE; Libby P; Thadhani RI; Jaffer FA
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):189-96. PubMed ID: 25395614
[TBL] [Abstract][Full Text] [Related]
45. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
Tang J; Xie Q; Pan G; Wang J; Wang M
Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
[TBL] [Abstract][Full Text] [Related]
46. Osteopontin mediation of disturbed flow-induced endothelial mesenchymal transition through CD44 is a novel mechanism of neointimal hyperplasia in arteriovenous fistulae for hemodialysis access.
Chang CJ; Lai YJ; Tung YC; Wu LS; Hsu LA; Tseng CN; Chang GJ; Yang KC; Yeh YH
Kidney Int; 2023 Apr; 103(4):702-718. PubMed ID: 36646166
[TBL] [Abstract][Full Text] [Related]
47. Arterially transplanted mesenchymal stem cells in a mouse reversible unilateral ureteral obstruction model: in vivo bioluminescence imaging and effects on renal fibrosis.
Bai ZM; Deng XD; Li JD; Li DH; Cao H; Liu ZX; Zhang J
Chin Med J (Engl); 2013; 126(10):1890-4. PubMed ID: 23673105
[TBL] [Abstract][Full Text] [Related]
48. Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation.
Cui B; Huang L; Fang Y; Guo R; Yin Y; Zhao X
Microvasc Res; 2011 Jan; 81(1):143-50. PubMed ID: 20888843
[TBL] [Abstract][Full Text] [Related]
49. Mesenchymal stem cells induce an inflammatory response after intravenous infusion.
Hoogduijn MJ; Roemeling-van Rhijn M; Engela AU; Korevaar SS; Mensah FK; Franquesa M; de Bruin RW; Betjes MG; Weimar W; Baan CC
Stem Cells Dev; 2013 Nov; 22(21):2825-35. PubMed ID: 23767885
[TBL] [Abstract][Full Text] [Related]
50. Autologous mesenchymal stem cells prevent transplant arteriosclerosis by enhancing local expression of interleukin-10, interferon-γ, and indoleamine 2,3-dioxygenase.
Jui HY; Lin CH; Hsu WT; Liu YR; Hsu RB; Chiang BL; Tseng WY; Chen MF; Wu KK; Lee CM
Cell Transplant; 2012; 21(5):971-84. PubMed ID: 22449499
[TBL] [Abstract][Full Text] [Related]
51. Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury.
Shen J; Zhong XM; Duan XH; Cheng LN; Hong GB; Bi XB; Liu Y
Acad Radiol; 2009 Sep; 16(9):1142-54. PubMed ID: 19660710
[TBL] [Abstract][Full Text] [Related]
52. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
[TBL] [Abstract][Full Text] [Related]
53. Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats.
Hanabusa K; Nagaya N; Iwase T; Itoh T; Murakami S; Shimizu Y; Taki W; Miyatake K; Kangawa K
Stroke; 2005 Apr; 36(4):853-8. PubMed ID: 15746464
[TBL] [Abstract][Full Text] [Related]
54. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
[TBL] [Abstract][Full Text] [Related]
55. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
56. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model.
Wan CD; Cheng R; Wang HB; Liu T
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):29-33. PubMed ID: 18234635
[TBL] [Abstract][Full Text] [Related]
57. Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: role of vitamin K treatment?
Zaragatski E; Grommes J; Schurgers LJ; Langer S; Kennes L; Tamm M; Koeppel TA; Kranz J; Hackhofer T; Arakelyan K; Jacobs MJ; Kokozidou M
Kidney Int; 2016 Mar; 89(3):601-11. PubMed ID: 26466318
[TBL] [Abstract][Full Text] [Related]
58. Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation.
Kim JW; Ha KY; Molon JN; Kim YH
Spine (Phila Pa 1976); 2013 Aug; 38(17):E1065-74. PubMed ID: 23629485
[TBL] [Abstract][Full Text] [Related]
59. Adventitial delivery of lentivirus-shRNA-ADAMTS-1 reduces venous stenosis formation in arteriovenous fistula.
Nieves Torres EC; Yang B; Roy B; Janardhanan R; Brahmbhatt A; Leof E; Mukhopadhyay D; Misra S
PLoS One; 2014; 9(4):e94510. PubMed ID: 24732590
[TBL] [Abstract][Full Text] [Related]
60. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
